Ko HW - Search Results

1

Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan.

Hsu PC, Lee SH, Chiu LC, Lee CS, Wu CE, Kuo SC, Ju JS, Huang AC, Li SH, Ko HW, Yang CT, Wang CC. Hsu PC, et al. Among authors: ko hw. Target Oncol. 2023 Mar;18(2):195-207. doi: 10.1007/s11523-023-00946-w. Epub 2023 Feb 20. Target Oncol. 2023. PMID: 36805452 Free PMC article.

2

Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the Allele Frequency Fraction of Acquired T790M and the Subsequent Efficacy of Osimertinib.

Kuo CS, Huang CH, Liu CY, Pavlidis S, Ko HW, Chung FT, Lin TY, Wang CL, Guo YK, Yang CT. Kuo CS, et al. Among authors: ko hw. Target Oncol. 2019 Aug;14(4):433-440. doi: 10.1007/s11523-019-00657-1. Target Oncol. 2019. PMID: 31346928

3

Front-line treatment of ceritinib improves efficacy over crizotinib for Asian patients with anaplastic lymphoma kinase fusion NSCLC: The role of systemic progression control.

Huang SH, Huang AC, Wang CC, Chang WC, Liu CY, Pavlidis S, Ko HW, Chung FT, Hsu PC, Guo YK, Kuo CS, Yang CT. Huang SH, et al. Among authors: ko hw. Thorac Cancer. 2019 Dec;10(12):2274-2281. doi: 10.1111/1759-7714.13221. Epub 2019 Oct 15. Thorac Cancer. 2019. PMID: 31613427 Free PMC article.

4

Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancer.

Chu CH, Chiu TH, Wang CC, Chang WC, Huang AC, Liu CY, Wang CL, Ko HW, Chung FT, Hsu PC, Guo YK, Kuo CS, Yang CT. Chu CH, et al. Among authors: ko hw. Thorac Cancer. 2020 Jun;11(6):1541-1549. doi: 10.1111/1759-7714.13426. Epub 2020 Apr 13. Thorac Cancer. 2020. PMID: 32281272 Free PMC article.

5

Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation.

Kuo CS, Chiu TH, Tung PH, Huang CH, Ju JS, Huang AC, Wang CC, Ko HW, Hsu PC, Fang YF, Guo YK, Yang CT. Kuo CS, et al. Among authors: ko hw. Cancers (Basel). 2022 Jan 9;14(2):316. doi: 10.3390/cancers14020316. Cancers (Basel). 2022. PMID: 35053480 Free PMC article.

6

The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis.

Chiu TH, Tung PH, Huang CH, Ju JS, Huang AC, Wang CC, Ko HW, Hsu PC, Fang YF, Guo YK, Kuo CS, Yang CT. Chiu TH, et al. Among authors: ko hw. Sci Rep. 2022 Mar 15;12(1):4398. doi: 10.1038/s41598-022-08449-w. Sci Rep. 2022. PMID: 35292755 Free PMC article.

7

Clinical outcome analysis of non-small cell lung cancer patients with brain metastasis receiving metastatic brain tumor resection surgery: a multicenter observational study.

Hsu PC, Chiu LC, Chen KT, Wang CC, Wu CT, Wu CE, Ko HW, Kuo SC, Lin YC, Wang CC, Yang CT. Hsu PC, et al. Among authors: ko hw. Am J Cancer Res. 2023 Aug 15;13(8):3607-3617. eCollection 2023. Am J Cancer Res. 2023. PMID: 37693127 Free PMC article.

8

Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2nd-generation EGFR-tyrosine kinase inhibitors.

Hsu PC, Huang CY, Lin YC, Lee SH, Chiu LC, Wu CE, Kuo SC, Ju JS, Huang AC, Ko HW, Wang CC, Yang CT. Hsu PC, et al. Among authors: ko hw. Front Oncol. 2023 Oct 3;13:1249106. doi: 10.3389/fonc.2023.1249106. eCollection 2023. Front Oncol. 2023. PMID: 37854677 Free PMC article.

9

Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study.

Chiu LC, Lee CS, Hsu PC, Li HH, Chan TM, Hsiao CC, Kuo SC, Ko HW, Lin SM, Wang CH, Lin HC, Chu PH, Yen TH. Chiu LC, et al. Among authors: ko hw. Environ Health. 2024 Mar 19;23(1):29. doi: 10.1186/s12940-024-01070-6. Environ Health. 2024. PMID: 38504259 Free PMC article.

10

Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer.

Chiu LC, Hsu PC, Wang CC, Ko HW, Kuo SC, Ju JS, Tung PH, Huang AC, Yang CT. Chiu LC, et al. Among authors: ko hw. Thorac Cancer. 2024 Mar;15(7):529-537. doi: 10.1111/1759-7714.15212. Epub 2024 Jan 26. Thorac Cancer. 2024. PMID: 38279515 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page